1. Market Research
  2. > Cancer Industry

Lymphoma Industry, June 2016 Market Reports from Top Publishers

You might be interested in: Diagnostics, Cancer, Therapy, Leukemia, Clinical Trial, Nuclear Imaging Equipment, Pap Smear, Bone Marrow Transplant, Blood Disease, Nuclear Medicine, Blood Supply, Cancer Diagnostic, Monoclonal Antibody, Prostate Cancer.


 
1-10 of about 300 reports for Lymphoma

Purchase Reports From Reputable Market Research Publishers

Cutaneous T-Cell Lymphoma Global Clinical Trials Review, H1, 2016

Cutaneous T-Cell Lymphoma Global Clinical Trials Review, H1, 2016

  • $ 2 500
  • Industry report
  • May 2016
  • by Global Data

Cutaneous T-Cell Lymphoma Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Cutaneous T-Cell Lymphoma Global Clinical Trials Review, H1, 2016" provides an overview ...

Global Non-Hodgkin Lymphoma Partnering 2010 to 2016

Global Non-Hodgkin Lymphoma Partnering 2010 to 2016

  • $ 1 495
  • Industry report
  • June 2016
  • by Currentpartnering

The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies. - Trends ...

Global Lymphoma Partnering 2010 to 2016

Global Lymphoma Partnering 2010 to 2016

  • $ 1 495
  • Industry report
  • June 2016
  • by Currentpartnering

The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies. - Trends ...

Treatment of Non-Hodgkin Lymphoma - Patent Overview in the years 2011 - 2016

Treatment of Non-Hodgkin Lymphoma - Patent Overview in the years 2011 - 2016

  • $ 500
  • Industry report
  • June 2016
  • by Mordor Intelligence LLP

Non-Hodgkin's lymphoma, also called non-Hodgkin lymphoma, is cancer that originates in your lymphatic system, the disease-fighting network spread throughout your body. In non-Hodgkin's lymphoma, tumors ...

Treatment of Cutaneous T-Cell Lymphoma - Patent Overview in the years 2011 - 2016

Treatment of Cutaneous T-Cell Lymphoma - Patent Overview in the years 2011 - 2016

  • $ 500
  • Industry report
  • June 2016
  • by Mordor Intelligence LLP

Cutaneous lymphomas are a distinct subset of non-Hodgkin’s lymphoma. They are cancers of lymphocytes (white blood cells) that primarily involve the skin. Classification is based on lymphocyte type - ...

Treatment of Primary CNS Lymphoma - Patent Overview in the years 2011 - 2016

Treatment of Primary CNS Lymphoma - Patent Overview in the years 2011 - 2016

  • $ 500
  • Industry report
  • June 2016
  • by Mordor Intelligence LLP

Primary central nervous system (CNS) lymphoma is a non-Hodgkin's lymphoma that arises within and is restricted to the nervous system. It usually presents as a brain tumor, but may also involve the leptomeninges, ...

Treatment of Hodgkin Lymphoma - Patent Overview in the years 2011 - 2016

Treatment of Hodgkin Lymphoma - Patent Overview in the years 2011 - 2016

  • $ 500
  • Industry report
  • June 2016
  • by Mordor Intelligence LLP

Hodgkin lymphoma is considered to be a curable malignancy, but therapies for this disease can have significant long-term toxicity. General treatment modalities include radiation therapy, induction chemotherapy, ...

Non-Hodgkin Lymphoma - Pipeline Review, H1 2016

Non-Hodgkin Lymphoma - Pipeline Review, H1 2016

  • $ 2 000
  • Company report
  • May 2016
  • by Global Markets Direct

Non-Hodgkin Lymphoma - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Non-Hodgkin Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Non-Hodgkin Lymphoma pipeline landscape. ...

Diffuse Large B-Cell Lymphoma Global Clinical Trials Review, H1, 2016

Diffuse Large B-Cell Lymphoma Global Clinical Trials Review, H1, 2016

  • $ 2 500
  • Industry report
  • May 2016
  • by Global Data

Diffuse Large B-Cell Lymphoma Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Diffuse Large B-Cell Lymphoma Global Clinical Trials Review, H1, 2016" provides an overview ...

Indolent Lymphoma Global Clinical Trials Review, H1, 2016

Indolent Lymphoma Global Clinical Trials Review, H1, 2016

  • $ 2 500
  • Industry report
  • May 2016
  • by Global Data

Indolent Lymphoma Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Indolent Lymphoma Global Clinical Trials Review, H1, 2016" provides an overview of Indolent Lymphoma ...

About 4 800 reports for Lymphoma

Download Unlimited Documents from Trusted Public Sources

Therapy Market and Infectious Disease Statistics in the US

  • January 2015
    270 pages
  • Therapy  

    Infectious Dise...  

    Blood Disease  

  • United States  

View report >

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.